Incyte Reports First Quarter Financial Results and Positive Clinical Progress in Multiple Programs
Click here to view press release
Incyte to Provide Update on Clinical Programs at Cowen Health Care Conference
Click here to view press release
Click here to view presentation
Data Presented At The American Society of Hematology 49th Meeting Demonstrate That Incyte's Novel JAK Inhibitor, INCB18424, Provides Rapid and Profound Clinical Benefits in Myelofibrosis Patients
Click here to view press release
Click here to view ASH presentation
Click here to view JAK backgrounder
